Fox Run Management’s ESSA Pharma EPIX Stock Holding History

Fox Run Management’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,102	Closed	-$89K	–	538
2021 Q3	$89K	Buy	+11,102	New	+$177K	0.06%	434

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Fox Run Management's EPIX Position: Q4 2021 in Review

Fox Run Management sold out of ESSA Pharma (EPIX) in Q4 2021, closing a stake of 11,102 shares — an estimated $89K sold.

Fox Run Management first reported a position in EPIX in Q3 2021 and held it in 1 quarter. The position peaked at $89K in Q3 2021. 60 funds tracked by Wall St. Rank hold EPIX as of Q4 2021.

Fox Run Management reported no remaining ESSA Pharma position as of Q4 2021 after selling out during the quarter.
Fox Run Management sold 11,102 ESSA Pharma shares in Q4 2021, an estimated $89K.
Fox Run Management first reported a position in ESSA Pharma in Q3 2021 and held it in 1 quarter.
Fox Run Management's ESSA Pharma position peaked at $89K in Q3 2021.
60 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2021.

Based on Fox Run Management's 13F filing for Q4 2021, filed 9 Feb 2022.